These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3840645)

  • 1. Leu-M1 positivity not specific for Hodgkin's disease.
    Sheibani K; Battifora H
    Am J Clin Pathol; 1985 Nov; 84(5):682-4. PubMed ID: 3840645
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of Leu M1 and antiepithelial membrane antigen monoclonal antibodies for diagnosing Hodgkin's disease.
    Jack AS; Cunningham D; Soukop M; Liddle CN; Lee FD
    J Clin Pathol; 1986 Mar; 39(3):267-70. PubMed ID: 3514684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of Leu M1 monoclonal antibody in the differential diagnosis of Hodgkin's disease.
    Hyder DM; Schnitzer B
    Arch Pathol Lab Med; 1986 May; 110(5):416-9. PubMed ID: 3516118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Granulocyte and HLA-D region specific monoclonal antibodies in the diagnosis of Hodgkin's disease.
    Norton AJ; Isaacson PG
    J Clin Pathol; 1985 Nov; 38(11):1241-6. PubMed ID: 3864794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of the monoclonal antibody Leu-M1 in the diagnosis of Hodgkin's disease].
    Zoppi JA; Larregina A; Anaya J; Avagnina A; Elsner B
    Medicina (B Aires); 1987; 47(3):329-30. PubMed ID: 3441213
    [No Abstract]   [Full Text] [Related]  

  • 6. The spectrum of Leu-M1 staining in lymphoid and hematopoietic proliferations.
    Swerdlow SH; Wright SA
    Am J Clin Pathol; 1986 Mar; 85(3):283-8. PubMed ID: 2428238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reliability of anti-Leu-M1 immunostaining in Hodgkin's disease.
    Carbone A; Poletti A; Manconi R; Volpe R; Betta PG
    Arch Pathol Lab Med; 1986 Jun; 110(6):465-6. PubMed ID: 3754715
    [No Abstract]   [Full Text] [Related]  

  • 8. Leu M1 and S100 in Hodgkin's disease and non-Hodgkin's lymphomas.
    Kornstein MJ; Bonner H; Gee B; Cohen R; Brooks JJ
    Am J Clin Pathol; 1986 Apr; 85(4):433-7. PubMed ID: 3754087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitivity of anti-Leu-M1 as a marker in Hodgkin's disease.
    Frierson HF; Innes DJ
    Arch Pathol Lab Med; 1985 Nov; 109(11):1024-8. PubMed ID: 3840354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An evaluation of the utility of anti-granulocyte and anti-leukocyte monoclonal antibodies in the diagnosis of Hodgkin's disease.
    Dorfman RF; Gatter KC; Pulford KA; Mason DY
    Am J Pathol; 1986 Jun; 123(3):508-19. PubMed ID: 3717303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic expression of Hodgkin's and Reed-Sternberg cells in Hodgkin's disease.
    Hsu SM; Yang K; Jaffe ES
    Am J Pathol; 1985 Feb; 118(2):209-17. PubMed ID: 3970138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leu-M1--a marker for Reed-Sternberg cells in Hodgkin's disease. An immunoperoxidase study of paraffin-embedded tissues.
    Pinkus GS; Thomas P; Said JW
    Am J Pathol; 1985 May; 119(2):244-52. PubMed ID: 3887932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of LeuM1 monoclonal antibody for the diagnosis of Hodgkin's disease.
    Memon GM; Alam SM
    J Pak Med Assoc; 1990 Jul; 40(7):156-9. PubMed ID: 1980316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of phenotyping by Ber-H2, Leu-M1, EMA in Hodgkin's disease.
    de Mascarel I; Trojani M; Eghbali H; Coindre JM; Bonichon F
    Arch Pathol Lab Med; 1990 Sep; 114(9):953-5. PubMed ID: 1975165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced staining for Leu M1 (CD15) in Hodgkin's disease using a secondary antibody specific for immunoglobulin M.
    LeBrun DP; Kamel OW; Dorfman RF; Warnke RA
    Am J Clin Pathol; 1992 Jan; 97(1):135-8. PubMed ID: 1345892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leu 7 (CD57) reactivity distinguishes nodular lymphocyte predominance Hodgkin's disease from nodular sclerosing Hodgkin's disease, T-cell-rich B-cell lymphoma and follicular lymphoma.
    Kamel OW; Gelb AB; Shibuya RB; Warnke RA
    Am J Pathol; 1993 Feb; 142(2):541-6. PubMed ID: 7679553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of CD15 immunostaining in diagnosing Hodgkin's disease: a review of published literature.
    Hall PA; D'Ardenne AJ
    J Clin Pathol; 1987 Nov; 40(11):1298-304. PubMed ID: 3320093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-Hodgkin's lymphoma following Hodgkin's disease. A case report and immunohistochemical corroboration.
    Shimizu K; Hara K; Kunii A
    Am J Clin Pathol; 1986 Sep; 86(3):370-4. PubMed ID: 3529930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-Leu-3a antibody reactivity with Reed-Sternberg cells of Hodgkin's disease.
    Oka K; Mori N; Kojima M
    Arch Pathol Lab Med; 1988 Feb; 112(2):139-42. PubMed ID: 3257383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leu M1 and peanut agglutinin stain the neoplastic cells of Hodgkin's disease.
    Hsu SM; Jaffe ES
    Am J Clin Pathol; 1984 Jul; 82(1):29-32. PubMed ID: 6741873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.